---
title: "Americold's Joint Venture with EQT Partners Boosts COLD +2.56%"
canonical_url: https://www.stockexpertai.com/journal/2026-05-23/americolds-joint-venture-with-eqt-partners-boosts-cold-256-3
last_updated: 2026-05-23T18:19:24.958Z
section: "Opinion Note"
author: "The StreetNews Editorial Board"
publisher: Stock Expert AI
tickers: COLD, EQT, IBRX, VERI, UBER, DASH, SO
content_type: journal-article
---

# Americold's Joint Venture with EQT Partners Boosts COLD +2.56%

## The Take
- Focus on companies with strong fundamentals and growth strategies, while carefully assessing risks associated with regulatory scrutiny.

_Americold gains on JV unlocking $1.1B as IBRX faces lawsuit over misleading claims._

Here's our take on what matters most today.

Americold Realty Trust (COLD) is showing positive momentum, with shares up +2.56% following news of its transformational joint venture with EQT Partners. This partnership unlocks $1.1 billion in proceeds, accelerating the company's deleveraging efforts and highlighting a significant public-private valuation gap. Americold is also experiencing gains in its international operations, particularly in Europe, which are driving occupancy and throughput.

Conversely, ImmunityBio (IBRX) is facing headwinds, with shares down -6.72% amid a securities class action lawsuit. The lawsuit follows an FDA warning letter regarding misleading efficacy claims made by the company's executive chairman about its lead biologic product, Anktiva. The FDA's action and subsequent market reaction underscore the importance of regulatory compliance and transparent communication in the biotech industry.

Stay informed. Stay disciplined. Stay ahead.

## Related Tickers
- [COLD](https://www.stockexpertai.com/stock/cold)
- [EQT](https://www.stockexpertai.com/stock/eqt)
- [IBRX](https://www.stockexpertai.com/stock/ibrx)
- [VERI](https://www.stockexpertai.com/stock/veri)
- [UBER](https://www.stockexpertai.com/stock/uber)
- [DASH](https://www.stockexpertai.com/stock/dash)
- [SO](https://www.stockexpertai.com/stock/so)

## Frequently Asked Questions

### Why is Americold (COLD) stock price increasing?
Americold's stock is up due to a joint venture with EQT Partners, which unlocks $1.1 billion in proceeds. This is helping the company deleverage and is also boosted by gains in its international operations, particularly in Europe, which are driving occupancy and throughput.

### Why is ImmunityBio (IBRX) stock price decreasing?
ImmunityBio's stock is down due to a securities class action lawsuit following an FDA warning letter. The letter cited misleading efficacy claims made by the company's executive chairman about its lead biologic product, Anktiva.

---
_AI-generated under human editorial supervision. Educational research, not financial advice._